Neuralink
Series D
22, 2023
Funding rounds
Series D
22, 2023
$3.5B
Valuation$323.2M
Amount raisedInvestors
Series C
r 30, 2021
$2.1B
Valuation$205.9M
Amount raisedInvestors
Series B
a 28, 2019
$522M
Valuation$51M
Amount raisedInvestors
_logo.png){kind=logo}
Investors
Dreamers VC
Investor
Series B
Valor Equity Partners
Investor
Series C
Series B
Craft Ventures
Investor
Series B
Series C
Future Ventures (San Francisco)
Investor
Series B
DFJ Growth
Investor
Series B
Series C
Crescent Hill Capital
Investor
Series B
E1 Ventures
Investor
Series D
Setcoin Group
Investor
Series D
The ECI Group
Investor
Series D
MarketX
Investor
Series D
Founders Fund
Investor
Series C
Series D
Advaita Capital
Investor
Series D
Type One Ventures
Investor
Series D
Soul Ventures
Investor
Series D
Redefine Ventures
Investor
Series D
Knockout Capital
Investor
Series D
IPO Club
Investor
Series D
Capital Advantage Ventures
Investor
Series D
Oak Grove Ventures
Investor
Series D
Raison
Investor
Series C
Sam Altman
Investor
Series C
Page One Ventures
Investor
Series C
Time BioVentures
Investor
Series C
Vy Capital
Investor
Series C
Fred Ehrsam
Investor
Series C
S32
Investor
Series C
Vantage Legacy Capital
Investor
Series C
GigaFund
Investor
Series C
Blake Byers
Investor
Series C
Robert Nelson
Investor
Series C
GV
Investor
Series C
Alphabet
Investor
Series C
Ken Howery
Investor
Series C
EXOR Seeds
Investor
Series C
General Info
Overview
Developer of an implantable brain-machine interface designed to help people with paralysis. The company's interface is designed to treat and diagnose neurological conditions in humans and conceivably augment human cognitive powers, enabling doctors to treat serious brain diseases in the short term.
Headquarters Regions
Fremont, 94555